Back in October 2019, at Senator Cramer’s invitation, VA Secretary Robert Wilkie and the Senator toured Healing with Hyperbarics of North Dakota, a Fargo-based HBOT clinic. Cramer states, “The primary point of the federal government is the defense of our nation. Part...
Brain Damage News
Hyperbaric Oxygen Therapy (HBOT) News for Brain Damage
Oxygen Under Pressure Resolving TBI’s & Suicide – Hailed as Most Important Scientific Breakthrough for 2019
Research Triangle Park, NC (January 21, 2020) - Congressman Andy Biggs (AZ-05) and Senator Kevin Cramer (R-ND) recently introduced the TBI and PTSD Treatment Act [House Bill 4370; Senate Bill 2504], in late 2019 to direct the Veterans Administration (VA) to furnish...
Local doctor continues to push VA to approve Hyperbaric Oxygen Therapy for veterans
The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture.
Study Reveals Oxygen-Rich Air Can Reverse Severe Brain Damage
The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture.
Dying for a cure
CINCINNATI (WKRC) - Suicide among our members of the military and our veterans is now at its highest level ever, reaching an average of 24 deaths a day. Several scientific and medical studies link many of these suicides to physical brain damage suffered by combat...
Hyperbaric oxygen therapy benefits in concussion management
Many Oklahomans suffer from debilitating conditions resulting from head trauma. Brain injuries may result from active duty military service, sports activities, automobile accidents, and from a host of other traumatic events. State Rep. Jay Steagall (R-Yukon), chair of...
Fargo VA to offer hyperbaric oxygen therapy for vets as part of pilot program
Other four facilities in the program have a 100% success rate in helping brain wounds for veteransHEALING UNDER PRESSURE: HYPERBARIC OXYGEN THERAPY (HBOT) CLINICAL DEMONSTRATION EXPANDS TO TWO MORE SITESVeterans in South-Central Texas and Central Florida diagnosed...
Micheal Bear Clair HBOT Story
Michael Bear Clair is a former Professional wrestler and Nashville Session player and lifelong touring musician. He spent his teen years and adult life playing music for a living and playing with some of the biggest stars in the music industry including Steve Miller,...
New law gives veterans option to seek oxygen-based therapy for PTSD
North Carolina’s veterans gained another way to treat battlefield trauma. With Gov. Roy Cooper signing House Bill 50 into law, Veterans Administration physicians can treat veterans with post traumatic stress disorder or a traumatic brain injury with hyperbaric oxygen...